Clarity Pharmaceuticals Director Adjusts Holdings

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.

Clarity Pharmaceuticals Ltd. has issued a change of director’s interest notice, disclosing that Dr. Alan Taylor has adjusted his holdings in the company. Dr. Taylor has exercised 1,200,000 options and acquired 1,083,776 fully paid ordinary shares, valued at $990,000. Following these transactions, he now holds a total of 1,626,778 fully paid ordinary shares, with additional options still available for exercise in the future.

For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.